<code id='EE34F76C75'></code><style id='EE34F76C75'></style>
    • <acronym id='EE34F76C75'></acronym>
      <center id='EE34F76C75'><center id='EE34F76C75'><tfoot id='EE34F76C75'></tfoot></center><abbr id='EE34F76C75'><dir id='EE34F76C75'><tfoot id='EE34F76C75'></tfoot><noframes id='EE34F76C75'>

    • <optgroup id='EE34F76C75'><strike id='EE34F76C75'><sup id='EE34F76C75'></sup></strike><code id='EE34F76C75'></code></optgroup>
        1. <b id='EE34F76C75'><label id='EE34F76C75'><select id='EE34F76C75'><dt id='EE34F76C75'><span id='EE34F76C75'></span></dt></select></label></b><u id='EE34F76C75'></u>
          <i id='EE34F76C75'><strike id='EE34F76C75'><tt id='EE34F76C75'><pre id='EE34F76C75'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:comprehensive    Page View:38665
          Calling Bullshit course University of Washington
          Screenshot via callingbullshit.org

          Tired of alternative facts, fake news, and breathless hyperbole, two professors at the University of Washington are trying to strike a blow for science.

          Their weapon? A new course: “Calling Bullshit In the Age of Big Data.”

          advertisement

          The class website and colorful syllabus went online last month and almost instantly went viral.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more
          US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears
          US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

          2:04Inanundatedstockphoto,awomancarryingashoppingbasket,shopsaloneatasupermarket.STOCKPHOTO/GettyIma

          read more
          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more

          Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

          YichuanCao/SipaUSAviaAPImagesGileadSciencessaidMondaythatTrodelvy,its“smart-bomb”medicinethatcombine